Purchase Order 75N91023P00542
Award Date 6/27/23
Potential Completion Date 6/26/26
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
- This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing...
- The National Institutes of Health's National Cancer Institute awarded a $249,323 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital. This contract is to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. Per the statement of work, the center will coordinate data collection and analysis from multiple pediatric cancer treatment sites comparing outcomes of patients...
- The National Cancer Institute (NCI) awarded a $249,997 firm fixed-price purchase order to The Washington University's Office of Sponsored Research Services on November 1, 2024, for medical record abstraction services supporting the Pediatric Proton and Photon Therapy Comparison Cohort study. Under this 14-month contract through June 30, 2026, Washington University will retrieve and abstract de-identified clinical and treatment data from medical records of pediatric cancer patients who received...
- This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. The $624,994 contract will run from September 2024 to March 2027. The contractor will assemble existing data from medical records for a group of pediatric cancer patients...
- This firm fixed price purchase order awarded by the National Institutes of Health's National Cancer Institute to Mayo Clinic seeks to obtain clinical data on pediatric cancer patients treated with proton therapy or photon therapy. The goal is to retrieve existing diagnosis and treatment data from medical records of eligible patients treated since January 2007 at contractor institutions and enter de-identified data into a secure database to serve as a comparison cohort for a US Pediatric Proton...
- The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...
- This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI) to Princeton Procure Management LLC (Procure Proton Center) for $150,150 to provide medical record abstraction services for a study comparing pediatric proton and photon radiotherapy. The 14-month contract, which starts on or about November 1, 2024, is part of NCI's Pediatric Proton and Photon Therapy Comparison Cohort program. The contractor will retrieve de-identified clinical and treatment data from medical...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit hospital and research institution. The $249,997.00 contract will obtain data on a cohort of pediatric cancer patients treated with proton therapy and a comparison group treated with photon therapy, to serve as part of a...